№ files_lp_3_process_9_13040
File format: docx
Character count: 1602
File size: 18 KB
Statutory source outlining the procedures and criteria for notifying and evaluating compensation claims by guardians, conservators, attorneys, or guardians ad litem within estate proceedings.
Year:
2023
Region / Jurisdiction:
California, United States
Subject:
Guardianship and conservatorship compensation
Document type:
Statute
Authority / Institution:
California Legislature
Applicable parties:
Guardians, conservators, attorneys, guardians ad litem
Requirements:
Written notice of compensation, court approval, reasonableness and necessity evaluation
Procedures:
Filing statements, providing copies to interested parties, notifying changes at least 30 days in advance
Factors for evaluation:
Benefit to ward, customary fees, estate size, efficiency, delegation, other relevant considerations
Burden of proof:
Person seeking compensation must demonstrate reasonableness and necessity
Legal reference:
Sections 145309 and 145405
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Note:
Year
Subject:
Procurement
Document Type:
Form
Organization:
RCUH
Target Audience:
University officials, Fiscal Administrators, Principal Investigators, Department Heads, Administrators
Program:
Housing Choice Voucher (HCV) Program
Governing Regulations:
24 CFR 982 Subpart I; 24 CFR 982.507; 24 CFR 982.401; 24 CFR 100.203; 28 CFR 35.151(c)
Federal Authority:
U.S. Department of Housing and Urban Development (HUD)
Local Authority:
Public Housing Agency (PHA); OHCD
Effective Date of Biennial Inspection Policy:
July 1, 2014
Subject Matter:
Housing Quality Standards (HQS); Rent Reasonableness; Unit Inspections; Accessibility Modifications
Document Type:
Administrative policy chapter
Applicable Housing Types:
HCV-assisted units; special housing types; homeownership units (as applicable)
Referenced Guidance:
Housing Choice Voucher Guidebook Chapter 10; HUD Housing Inspection Manual for Section 8 Housing; HUD Forms 52580 and 52580-A; HUD Notice 2003-31
Standards Covered:
Sanitary facilities; food preparation and refuse disposal; space and security; thermal environment; illumination and electricity; structure and materials; interior air quality; water supply; lead-based paint; access; site and neighborhood; sanitary condition; smoke detectors
Year:
1985
Region / City:
United Kingdom
Subject:
Landlord and tenant law
Document Type:
Application Form
Institution:
Residential Property Tribunal
Author:
Not specified
Target Audience:
Landlords, tenants, property managers
Effective Period:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2023
Region / City:
Plymouth, MA
Topic:
Financial feasibility analysis of a proposed ambulatory surgery center
Document type:
Financial report
Organization:
Beth Israel Lahey Health Surgery Center Plymouth, LLC
Author:
Meyers Brothers Kalicka, P.C.
Target audience:
Healthcare industry stakeholders, project investors
Period of validity:
2025-2029
Approval date:
January 26, 2023
Modification date:
N/A
Note:
Year
Theme:
Medical Equipment, Adaptive Devices
Document Type:
Medical Necessity Letter
Target Audience:
Insurance Providers, Medical Professionals
Organization:
Driscoll Health Plan
Document type:
Clinical policy and administrative guidelines
Revision date:
November 1, 2024
Geographic scope:
Texas
Programs referenced:
STAR, STAR Kids, CHIP
Subject area:
Therapy services prior authorization and medical necessity
Target audience:
Therapy providers and referring physicians
Authorization method:
Provider web portal and fax submission
Related forms:
Texas Standard Prior Authorization Request Form for Health Care Services (TARF), Therapy Referral Review by Ordering Physician Attestation Form
Effective policy elements:
Initial evaluations, re-evaluations, continuation of therapy, start of care rules
Coverage criteria:
Medical necessity based on clinical documentation
Source type:
Health plan policy guideline
Year:
2021
Region / City:
United States
Topic:
Medical Necessity Letter, Health Treatment
Document Type:
Medical Document
Organization / Institution:
Not specified
Author:
Not specified
Target Audience:
Medical professionals, healthcare providers
Period of validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2021
Region / City:
California, Arizona
Topic:
Energy Transmission, Public Utilities
Document Type:
Decision
Organization / Institution:
California Public Utilities Commission
Author:
California Public Utilities Commission
Target Audience:
Stakeholders in energy infrastructure and transmission
Effective Period:
N/A
Approval Date:
November 4, 2021
Date of Changes:
N/A
Year:
2025
Region / City:
United States
Theme:
Medical necessity letter
Document type:
Medical letter
Organization / Institution:
Takeda Pharmaceuticals U.S.A., Inc.
Author:
Takeda Pharmaceuticals U.S.A., Inc.
Target audience:
Physicians, insurance providers
Period of validity:
Not specified
Approval date:
Not specified
Date of changes:
Not specified
Note:
Date
Diagnosis:
G36.0, neuromyelitis optica [Devic]
Treatment:
UPLIZNA® (inebilizumab-cdon), injection, 1 mg
Reason for request:
Medical necessity for treatment of neuromyelitis optica spectrum disorder (NMOSD) with UPLIZNA
Enclosures:
Prescribing Information, clinical notes, FDA approval letter, patient relapse history, test results, etc.
Year:
2024
Region / City:
United States
Topic:
Medical Necessity Letter
Document Type:
Medical Letter
Organization / Institution:
Bausch + Lomb
Author:
Physician
Target Audience:
Healthcare providers, Payers
Action Period:
June 2024
Approval Date:
June 2024
Modification Date:
N/A
Document type:
Medical necessity letter
Therapeutic area:
Ophthalmology
Indication:
Reduction of intraocular pressure in open-angle glaucoma or ocular hypertension
Medication name:
VYZULTA (latanoprostene bunod ophthalmic solution)
Dosage strength:
0.024%
Drug class:
Prostaglandin analogue with nitric oxide–donating activity
Regulatory status:
FDA-approved prescription medication
Manufacturer:
Bausch & Lomb Inc.
Intended recipient:
Health insurance payer or medical director
Target population:
Patients with open-angle glaucoma or ocular hypertension
Clinical evidence referenced:
Phase 2 VOYAGER study; Phase 3 APOLLO and LUNAR studies; real-world retrospective studies
Safety information included:
Yes
References:
Peer-reviewed journals and prescribing information
Source type:
Industry-provided informational material
Year:
2025
Region / City:
Princeton, NJ
Theme:
Medical necessity documentation
Document Type:
Medical letter
Organization / Institution:
Bristol-Myers Squibb Company
Author:
<>
Target Audience:
Healthcare professionals, physicians
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2025
Jurisdiction:
West Virginia, United States
Type of document:
Legislative Act
Governing body:
West Virginia Legislature
Authors:
Delegates Riley, Linville, D. Cannon, Eldridge
Effective date:
April 11, 2025
Subject:
Public utilities regulation, water and sewer services, certificate of public convenience and necessity
Legal references:
§24-2-11, §31-15A-1 et seq. of the West Virginia Code
Scope:
Construction projects of water and sewer services for utilities with at least 4,500 customers and $3 million or more in annual revenues
Approval authority:
Public Service Commission, Infrastructure and Jobs Development Council
Decision timelines:
Standard projects 225–270 days, projects >$50 million 400 days
Year:
2023
Region / City:
United States
Subject:
Healthcare
Document Type:
Template
Institution / Organization:
Takeda Oncology
Author:
Takeda Oncology
Target Audience:
Healthcare providers, insurance companies
Effective Period:
Not specified
Approval Date:
Not specified
Modification Date:
Not specified
Note:
Date
Year:
2026
Region / City:
N/A
Topic:
Genetic Testing, Exome Sequencing
Document Type:
Letter
Organization / Institution:
N/A
Author:
N/A
Target Audience:
Healthcare providers, medical practitioners
Validity Period:
N/A
Approval Date:
N/A
Modification Date:
N/A
Program:
Illinois Early Intervention Program
State:
Illinois
Type of document:
Administrative form
Subject area:
Early intervention services
Focus:
Assistive technology justification
Target population:
Infants and toddlers enrolled in Early Intervention
Associated plan:
Individualized Family Service Plan (IFSP)
Required contributors:
Early Intervention evaluator, service coordinator, physician
Required approvals:
Physician signature
Content sections:
Demographic information, provider information, IFSP details, assessment and justification
Purpose:
Documentation of developmental necessity for assistive technology items
Note:
Year
Topic:
Medical Nutrition
Document Type:
Template Letter
Organization / Institution:
Abbott Nutrition
Author:
Physician
Target Audience:
Health Insurance Providers
Year:
2026
Region / City:
United States
Topic:
Occupational illness compensation, impairment evaluation
Document type:
Letter, response form
Organization / Institution:
U.S. Department of Labor, Office of Workers’ Compensation Programs
Author:
Unknown
Target audience:
Claimants under EEOICPA
Period of validity:
Indefinite
Approval date:
Not provided
Modification date:
Not provided